Keyes KA - Search Results

1

LY317615 decreases plasma VEGF levels in human tumor xenograft-bearing mice.

Keyes KA, Mann L, Sherman M, Galbreath E, Schirtzinger L, Ballard D, Chen YF, Iversen P, Teicher BA. Keyes KA, et al. Cancer Chemother Pharmacol. 2004 Feb;53(2):133-40. doi: 10.1007/s00280-003-0713-x. Epub 2003 Oct 31. Cancer Chemother Pharmacol. 2004. PMID: 14593497

2

Site-dependent angiogenic cytokine production in human tumor xenografts.

Keyes KA, Mann L, Teicher B, Alvarez E. Keyes KA, et al. Cytokine. 2003 Jan 21;21(2):98-104. doi: 10.1016/s1043-4666(03)00015-2. Cytokine. 2003. PMID: 12670449

3

Circulating angiogenic growth factor levels in mice bearing human tumors using Luminex Multiplex technology.

Keyes KA, Mann L, Cox K, Treadway P, Iversen P, Chen YF, Teicher BA. Keyes KA, et al. Cancer Chemother Pharmacol. 2003 Apr;51(4):321-7. doi: 10.1007/s00280-003-0572-5. Epub 2003 Mar 18. Cancer Chemother Pharmacol. 2003. PMID: 12721760

4

An in vitro tumor model: analysis of angiogenic factor expression after chemotherapy.

Keyes K, Cox K, Treadway P, Mann L, Shih C, Faul MM, Teicher BA. Keyes K, et al. Cancer Res. 2002 Oct 1;62(19):5597-602. Cancer Res. 2002. PMID: 12359773

5

Properties of bisphosphonates in the 13762 rat mammary carcinoma model of tumor-induced bone resorption.

Alvarez E, Westmore M, Galvin RJ, Clapp CL, Considine EL, Smith SJ, Keyes K, Iversen PW, Delafuente DM, Sulaimon S, Zambrano C, Ma L, Sato M, Martin TJ, Teicher BA, Galbreath EJ. Alvarez E, et al. Clin Cancer Res. 2003 Nov 15;9(15):5705-13. Clin Cancer Res. 2003. PMID: 14654555

6

Cytotoxic chemotherapy regimens that increase dose per cycle (dose intensity) by extending daily dosing from 5 consecutive days to 28 consecutive days and beyond.

Keyes KA, Albella B, LoRusso PM, Bueren JA, Parchment RE. Keyes KA, et al. Clin Cancer Res. 2000 Jun;6(6):2474-81. Clin Cancer Res. 2000. PMID: 10873102

7

Latent hematopoietic stem cell toxicity associated with protracted drug administration.

Keyes KA, Segovia JC, Bueren JA, Parchment RE, Albella B. Keyes KA, et al. Exp Hematol. 2001 Mar;29(3):286-94. doi: 10.1016/s0301-472x(00)00670-6. Exp Hematol. 2001. PMID: 11274755 Free article.

8

Technology use among the nation's medical examiner and coroner offices: Data from the 2018 Census of Medical Examiner and Coroner Offices.

Weinstein LC, Keyes KA, Brooks C, Ascolese MA, Smiley-McDonald HM, Ropero-Miller JD. Weinstein LC, et al. Among authors: keyes ka. Forensic Sci Int Synerg. 2024 May 17;8:100477. doi: 10.1016/j.fsisyn.2024.100477. eCollection 2024. Forensic Sci Int Synerg. 2024. PMID: 38800712 Free PMC article.

9

The impacts of governing agency: A comparison of resources in the patchwork of medicolegal death investigation systems.

Smiley-McDonald HM, Keyes KA, Wire S, Greenwell K, Santos NA, Ropero-Miller JD. Smiley-McDonald HM, et al. Among authors: keyes ka. Forensic Sci Int Synerg. 2024 Apr 12;8:100467. doi: 10.1016/j.fsisyn.2024.100467. eCollection 2024. Forensic Sci Int Synerg. 2024. PMID: 38638873 Free PMC article.

10

Mass fatality and disaster response preparedness across medical examiner and coroner offices in the United States.

Ascolese MA, Keyes KA, Ropero-Miller JD, Wire SE, Smiley-McDonald HM. Ascolese MA, et al. Among authors: keyes ka. Forensic Sci Int Synerg. 2024 Feb 14;8:100462. doi: 10.1016/j.fsisyn.2024.100462. eCollection 2024. Forensic Sci Int Synerg. 2024. PMID: 38439787 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters